Nikolaos Scoutaris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nikolaos Scoutaris has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ali Nokhodchi
School of Life Sciences, University of Sussex, Brighton BN1 9QG, UK
1 shared publication - Amalie Schousboe
Center for Eating and Feeding Disorders Research, Mental Health Center Ballerup, Copenhagen University Hospital – Mental Health Services Copenhagen, Ballerup, Denmark
1 shared publication Babur Z. Chowdhry
Faculty of Engineering and Science, University of Greenwich, Chatham Maritime, Kent, ME4 4TB, UK
1 shared publication- Bülent Uslu
Department of Anesthesiology, Zealand University Hospital, 4000 Roskilde, Denmark
1 shared publication - Dennis Douroumis
Faculty of Engineering and Science University of Greenwich Chatham Maritime Kent UK
1 shared publication - Henning Bay Nielsen
Department of Anesthesia and Intensive Care, Zealand University Hospital, 4000 Roskilde, Denmark
1 shared publication
Latest Publications
- Open Access
- 26 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (7) , 847
Lung Surfactant Deficiency in Severe Respiratory Failure: A Potential Biomarker for Clinical Assessment
Background/Objectives: Critical lung infection affects alveolar cells and probably also their ability to perform surfactant procedures, but bedside tools for monitoring lung surfactants are lacking. In this descriptive exploratory study, we aimed to evaluate lung surfactant levels in bronchial aspirate (BA) from patients admitted to the intensive care unit due to severe respiratory failure. Methods: Bronchial aspirates were collected from nine patients (median age: 72 years, range: 52–85) who required orotracheal intubation. Samples were obtained within 24 h of mechanical ventilation initiation (T1), after three days on a ventilator (T2), and on day seven (T3) for four patients. The concentration of dipalmitoylphosphatidylcholine (DPPC), a key surfactant component, was assessed in the lamellar body precipitate. Results: Across the nine patients at T1, the DPPC level was 12 µM (range: 3–20 µM). By T2, the DPPC level declined to 8 µM (range: 2–22 µM), with a statistically significant decrease from T1 (p = 0.0039). At T3, the DPPC level in four patients ranged from 2 to 5 µM, though the difference from T2 was not statistically significant. A surfactant biomarker would assist clinical decision-making when dealing with patients in severe respiratory failure where exogenous surfactant therapy may be considered. Conclusions: DPPC levels obtained from bronchial aspirate can be measured in patients with severe respiratory failure and may serve as a useful biomarker for lung surfactant status, which suggests the potential for bedside assessment in clinical practice with a dedicated test device.
- 26 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (7) , 847
Open AccessLung Surfactant Deficiency in Severe Respiratory Failure: A Potential Biomarker for Clinical Assessment
Background/Objectives: Critical lung infection affects alveolar cells and probably also their ability to perform surfactant procedures, but bedside tools for monitoring lung surfactants are lacking. In this descriptive exploratory study, we aimed to evaluate lung surfactant levels in bronchial aspirate (BA) from patients admitted to the intensive care unit due to severe respiratory failure. Methods: Bronchial aspirates were collected from nine patients (median age: 72 years, range: 52–85) who required orotracheal intubation. Samples were obtained within 24 h of mechanical ventilation initiation (T1), after three days on a ventilator (T2), and on day seven (T3) for four patients. The concentration of dipalmitoylphosphatidylcholine (DPPC), a key surfactant component, was assessed in the lamellar body precipitate. Results: Across the nine patients at T1, the DPPC level was 12 µM (range: 3–20 µM). By T2, the DPPC level declined to 8 µM (range: 2–22 µM), with a statistically significant decrease from T1 (p = 0.0039). At T3, the DPPC level in four patients ranged from 2 to 5 µM, though the difference from T2 was not statistically significant. A surfactant biomarker would assist clinical decision-making when dealing with patients in severe respiratory failure where exogenous surfactant therapy may be considered. Conclusions: DPPC levels obtained from bronchial aspirate can be measured in patients with severe respiratory failure and may serve as a useful biomarker for lung surfactant status, which suggests the potential for bedside assessment in clinical practice with a dedicated test device.
- Retraction
- 1 April 2020
- Published by Elsevier in Journal of Physics and Chemistry of Solids
- Vol. 139, 109368
Retraction notice to “Development and characterisation of semi-crystalline composite granules: The effect of particle chemistry and the electrostatic charging [J. Phys. Chem. Solids. 111, December 2017, 167–175]”
- 1 April 2020
- Published by Elsevier in Journal of Physics and Chemistry of Solids
- Vol. 139, 109368
RetractionRetraction notice to “Development and characterisation of semi-crystalline composite granules: The effect of particle chemistry and the electrostatic charging [J. Phys. Chem. Solids. 111, December 2017, 167–175]”